Citadel Advisors
MLSS icon

Citadel Advisors’s Milestone Scientific MLSS Stock Holding History

Citadel Advisors’s Portfolio MLSS Stock Details MLSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.1K Buy
167,135
+13,360
+9% +$3.73K ﹤0.01% 12417
2025
Q4 		$42K Buy
+153,775
New +$58.5K ﹤0.01% 12117
2025
Q3 		– Sell
-39,642
Closed -$25.2K – 13598
2025
Q2 		$25.2K Buy
+39,642
New +$36.4K ﹤0.01% 12053
2025
Q1 		– Sell
-62,438
Closed -$68.5K – 15171
2024
Q4 		$59.9K Buy
62,438
+39,274
+170% +$32.4K ﹤0.01% 12181
2024
Q3 		$21.1K Sell
23,164
-31,169
-57% -$29.2K ﹤0.01% 12737
2024
Q2 		$37.1K Buy
54,333
+14,286
+36% +$9.5K ﹤0.01% 12062
2024
Q1 		$24.9K Sell
40,047
-8,541
-18% -$5.61K ﹤0.01% 12850
2023
Q4 		$33.5K Buy
48,588
+8,694
+22% +$6.93K ﹤0.01% 12178
2023
Q3 		$36.7K Sell
39,894
-49,848
-56% -$52.5K ﹤0.01% 12100
2023
Q2 		$78.1K Buy
+89,742
New +$80.8K ﹤0.01% 11271
2023
Q1 		– Sell
-73,092
Closed -$35.1K – 15184
2022
Q4 		$35.1K Buy
73,092
+15,781
+28% +$10.2K ﹤0.01% 12563
2022
Q3 		$45K Sell
57,311
-99,111
-63% -$96.1K ﹤0.01% 11704
2022
Q2 		$143K Buy
156,422
+143,473
+1,108% +$146K ﹤0.01% 11030
2022
Q1 		$20K Sell
12,949
-29,303
-69% -$42.8K ﹤0.01% 13241
2021
Q4 		$87K Buy
+42,252
New +$92.9K ﹤0.01% 12846
2021
Q3 		– Sell
-25,326
Closed -$62K – 14335
2021
Q2 		$62K Buy
+25,326
New +$61.4K ﹤0.01% 13230
2021
Q1 		– Sell
-29,535
Closed -$63K – 13526
2020
Q4 		$63K Buy
+29,535
New +$52K ﹤0.01% 10476
2019
Q2 		– Sell
-80,914
Closed -$27K – 9599
2019
Q1 		$27K Buy
80,914
+53,592
+196% +$19.7K ﹤0.01% 9013
2018
Q4 		$9K Buy
27,322
+10,736
+65% +$5.75K ﹤0.01% 8938
2018
Q3 		$12K Buy
+16,586
New +$13.2K ﹤0.01% 9092
2017
Q2 		– Sell
-12,787
Closed -$17K – 7840
2017
Q1 		$17K Buy
+12,787
New +$17.9K ﹤0.01% 7288

Other funds holding MLSS

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Mariner
Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
WIA
World Investment Advisors Santa Barbara, California $6.2B AUM 19.68% 1-Year Est. Return
CIC
Carnegie Investment Counsel Pepper Pike, Ohio $4.99B AUM 23.08% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Citadel Advisors's MLSS Position: Q1 2026 in Review

Citadel Advisors increased its Milestone Scientific (MLSS) stake by 8.7% in Q1 2026, buying an estimated $3.73K and bringing the position to 167,135 shares worth $48.1K. The position accounts for ﹤0.01% of the portfolio, ranked #12417.

Citadel Advisors first reported a position in MLSS in Q1 2017 and has held it in 21 quarters since. The position peaked at $143K in Q2 2022. 32 funds tracked by Wall St. Rank hold MLSS as of Q1 2026.

  • Citadel Advisors held 167,135 shares of Milestone Scientific worth $48.1K as of Q1 2026.
  • Citadel Advisors bought 13,360 Milestone Scientific shares in Q1 2026, an estimated $3.73K.
  • Milestone Scientific made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12417 holding.
  • Citadel Advisors first reported a position in Milestone Scientific in Q1 2017 and has held it in 21 quarters since.
  • Citadel Advisors's Milestone Scientific position peaked at $143K in Q2 2022.
  • 32 funds tracked by Wall St. Rank held Milestone Scientific as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.